Doctor News and Research

RSS

Welbeck Health Partners adopts OMED Health’s home-based SIBO testing pathway across its network

OMED Health ("OMED"), part of Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, and Welbeck Health Partners ("Welbeck"), one of the UK's largest specialist outpatient healthcare providers, today announced that Welbeck has adopted OMED Health's home-based Small Intestinal Bacterial Overgrowth (SIBO) breath-testing pathway. The roll out across Welbeck's network follows a three-month evaluation where the pathway was assessed for performance and impact on standard of care.

From Welbeck Health Partners 25 Jun 2026

Genetic testing could sharply increase demand for ALS specialist care

The availability of genetic testing for amyotrophic lateral sclerosis (ALS) for people with a family member diagnosed with the disease is expected to greatly increase the number of clinic visits to specialized ALS centers over the next decade, according to a study published June 24, 2026, in Neurology Genetics, an official journal of the American Academy of Neurology.

24 Jun 2026

Computer simulations can drastically reduce endless wait times for medical care

New Rutgers research suggests much of the seemingly endless waiting for complex medical care can be engineered away by recreating operations inside a computer and testing countless possible improvements.

23 Jun 2026

Hyperemesis gravidarum increases risks for pregnancy and birth complications

Pregnant women with a severe form of nausea face increased risks for several pregnancy and birth complications, according to a new Stanford Medicine study of 2.5 million California births.

22 Jun 2026

Evolution of digital medicine is reshaping healthcare operations

At least 12 percent of Americans now communicate with their healthcare providers about appointments, test results, and ongoing treatments via secure online patient portals and health apps, a new study shows.

22 Jun 2026

International survey highlights major gaps in cardio-oncology education

An international survey has highlighted major gaps in cardio-oncology training, despite its increasing clinical importance. These results were presented at ESC Cardio-Oncology 2026, the second annual conference of the European Society of Cardiology's Council of Cardio-Oncology.

21 Jun 2026

NYU Langone performs the world's first HIV-positive-to-HIV-positive lung transplant

The world's first HIV-positive-to-HIV-positive lung transplant was performed at NYU Langone Health.

19 Jun 2026

Heart failure treatments protect heart function during cancer therapy

The cardioprotective effects of heart failure treatments in patients with cancer were demonstrated today in a presentation at ESC Cardio-Oncology 2026, the annual conference of the European Society of Cardiology's Council of Cardio-Oncology.

19 Jun 2026

Psychologist warns DNA testing kits can bring unexpected risks

DNA testing kits are often gifted for Father's Day, Christmas and special occasions. The idea of learning more about yourself and unearthing some long-forgotten family history is certainly appealing for many, but a psychologist has warned that these presents can come with profound psychological implications.

19 Jun 2026

Repeated low-level blast exposure linked to higher anger risk in veterans

Careers that tend to expose people to repeated low-level shockwaves are associated with a slightly higher risk of clinically documented anger, aggression, and violence, new research from University of Utah Health has found.

18 Jun 2026

New diagnostic tools aim to bridge long Covid knowledge gap

Five years after the first cases, patients with long Covid continue to go through months or years before receiving a diagnosis.

18 Jun 2026

Neurological disorders may raise traumatic brain injury risk in older adults

For traumatic brain injury (TBI) and certain brain diseases, it looks like the risk may go in both directions, according to a study published on June 17, 2026, in Neurology®, the medical journal of the American Academy of Neurology.

17 Jun 2026

Onion-loving gene linked to lower diabetes and blood pressure risk

Imagine if a doctor could look at your DNA and predict not just your disease risk, but also which foods you're drawn to – and whether those cravings are quietly protecting you.

17 Jun 2026

Age-related muscle loss linked to increased tumor growth

Duke-NUS scientists have discovered that aging muscle may contribute to cancer growth by releasing fewer extracellular vesicles, tiny particles that cells use to communicate with one another.

16 Jun 2026

UVA neurologist investigates Medicare policy effects on stroke patients

After identifying significant differences in stroke care and outcomes for patients on different Medicare plans, a UVA Health doctor is launching an ambitious effort to better understand the sources of those differences and ensure patients get the best care possible.

16 Jun 2026

Blood-based indicator assesses organ age to predict disease risk

The candles on your birthday cake don't tell the whole story. As anyone who ever attended a high-school reunion can tell you, some people age faster than others.

15 Jun 2026

Constant digital tracking of young adults backfires, fueling parental anxiety

Built-in smartphone apps and location sharing features allow parents to see where their children are at any moment: Did they arrive safely? Are they where they said they'd be? How far away are they if there's an emergency?

15 Jun 2026

Urine drug test may boost adherence to blood pressure medications

The largest ever UK trial of a urine test used across the NHS to spot when patients skip their medication has shown it may improve adherence to treatment.

12 Jun 2026

FDA approves new adjuvant treatment option for ccRCC patients with recurrence risk

The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2α inhibitor, as adjuvant treatment for adult patients with renal cell carcinoma with a clear cell component (ccRCC) at intermediate-high or high risk of recurrence following nephrectomy, with or without resection of metastatic lesions.

12 Jun 2026

New gel coating delivers anti-inflammatory antibodies directly to the esophagus

There are few treatment options available for people with disorders of the esophagus. Delivering drugs directly to this part of the body is difficult, so patients are usually treated with systemic drugs, which can have unwanted side effects.

12 Jun 2026